Temasek Holdings’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Temasek Holdings’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-352,379	Closed	-$1.84M	–	93
2023 Q2	$1.84M	Sell	352,379 -79,525	-18%	-$405K	0.01%	62
2023 Q1	$2.32M	Sell	431,904 -1	-0%	-$5	0.01%	60
2022 Q4	$1.6M	Hold	431,905	–	–	0.01%	66
2022 Q3	$2.16M	Hold	431,905	–	–	0.01%	71
2022 Q2	$2.52M	Buy	431,905 +331,905	+332%	+$1.87M	0.01%	84
2022 Q1	$712K	Hold	100,000	–	–	﹤0.01%	92
2021 Q4	$1.32M	Hold	100,000	–	–	﹤0.01%	88
2021 Q3	$2.3M	Hold	100,000	–	–	0.01%	78
2021 Q2	$4.39M	Hold	100,000	–	–	0.01%	82
2021 Q1	$7.26M	Hold	100,000	–	–	0.03%	59
2020 Q4	$4.32M	Hold	100,000	–	–	0.02%	67
2020 Q3	$4.11M	Hold	100,000	–	–	0.02%	64
2020 Q2	$6M	Hold	100,000	–	–	0.04%	49
2020 Q1	$7.53M	Hold	100,000	–	–	0.06%	48
2019 Q4	$13.8M	Hold	100,000	–	–	0.09%	47
2019 Q3	$11.9M	Hold	100,000	–	–	0.09%	46
2019 Q2	$14M	Hold	100,000	–	–	0.1%	44
2019 Q1	$17.9M	Hold	100,000	–	–	0.12%	39
2018 Q4	$15.7M	Buy	+100,000	New	+$14.9M	0.11%	50

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Temasek Holdings's ORTX Position: Q3 2023 in Review

Temasek Holdings sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2023, closing a stake of 352,379 shares — an estimated $1.84M sold.

Temasek Holdings first reported a position in ORTX in Q4 2018 and held it in 19 quarters. The position peaked at $17.9M in Q1 2019. 32 funds tracked by Wall St. Rank hold ORTX as of Q3 2023.

Temasek Holdings reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Temasek Holdings sold 352,379 Orchard Therapeutics plc American Depositary Shares shares in Q3 2023, an estimated $1.84M.
Temasek Holdings first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 19 quarters.
Temasek Holdings's Orchard Therapeutics plc American Depositary Shares position peaked at $17.9M in Q1 2019.
32 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2023.

Based on Temasek Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.